Carola Mix

445 total citations
13 papers, 320 citations indexed

About

Carola Mix is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Carola Mix has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 0 papers in Infectious Diseases. Recurrent topics in Carola Mix's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (8 papers). Carola Mix is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (8 papers). Carola Mix collaborates with scholars based in Germany. Carola Mix's co-authors include Markus Cornberg, Heiner Wedemeyer, Kerstin Port, Michael P. Manns, Katja Deterding, Christoph Höner zu Siederdissen, J. Kirschner, Benjamin Maasoumy, Heiko Mix and Antoaneta A. Markova and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Carola Mix

11 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carola Mix Germany 6 303 288 37 20 13 13 320
C. Hézode France 9 273 0.9× 251 0.9× 55 1.5× 20 1.0× 8 0.6× 37 309
Karl‐Georg Simon Germany 11 519 1.7× 515 1.8× 85 2.3× 13 0.7× 8 0.6× 33 550
Manuela Curescu Romania 9 259 0.9× 263 0.9× 29 0.8× 14 0.7× 4 0.3× 24 294
Alison Uriel United Kingdom 7 172 0.6× 150 0.5× 46 1.2× 10 0.5× 5 0.4× 10 211
Giampaolo Mangia Italy 7 239 0.8× 256 0.9× 31 0.8× 7 0.3× 8 0.6× 7 281
Beatriz Calle Serrano Germany 7 561 1.9× 568 2.0× 51 1.4× 9 0.5× 24 1.8× 9 605
E.J. Lawitz United States 12 393 1.3× 371 1.3× 93 2.5× 37 1.9× 8 0.6× 27 409
C John Germany 7 136 0.4× 131 0.5× 15 0.4× 25 1.3× 5 0.4× 21 160
S. Roberts Australia 10 276 0.9× 250 0.9× 69 1.9× 24 1.2× 3 0.2× 19 286
P. Mélin France 8 315 1.0× 282 1.0× 65 1.8× 15 0.8× 5 0.4× 20 335

Countries citing papers authored by Carola Mix

Since Specialization
Citations

This map shows the geographic impact of Carola Mix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carola Mix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carola Mix more than expected).

Fields of papers citing papers by Carola Mix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carola Mix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carola Mix. The network helps show where Carola Mix may publish in the future.

Co-authorship network of co-authors of Carola Mix

This figure shows the co-authorship network connecting the top 25 collaborators of Carola Mix. A scholar is included among the top collaborators of Carola Mix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carola Mix. Carola Mix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bremer, Birgit, Carola Mix, Tammo Lambert Tergast, et al.. (2024). Limited stability of Hepatitis B virus RNA in plasma and serum. Scientific Reports. 14(1). 27128–27128.
2.
Mix, Carola, et al.. (2019). Impact of HBsAg on HBV-specific immune responses in HBeAg negative patients with chronic hepatitis B. Zeitschrift für Gastroenterologie. 1 indexed citations
3.
Mix, Carola, et al.. (2019). FRI-131-Impact of HBsAg level on cellular immune responses in HBeAg negative patients with chronic hepatitis B virus infection. Journal of Hepatology. 70(1). e445–e445. 2 indexed citations
4.
Schlevogt, Bernhard, Katja Deterding, Kerstin Port, et al.. (2017). Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up. Zeitschrift für Gastroenterologie. 55(9). 848–856. 17 indexed citations
5.
Siederdissen, Christoph Höner zu, Benjamin Maasoumy, Steffen B. Wiegand, et al.. (2016). Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B. The Journal of Infectious Diseases. 214(10). 1492–1497. 92 indexed citations
6.
Schlevogt, Bernhard, Katja Deterding, Kerstin Port, et al.. (2016). Weight Gain after IFN-Free Cure of Chronic Hepatitis C: A Potential Concern?. Journal of Hepatology. 64(2). S750–S750. 4 indexed citations
7.
Deterding, Katja, Christoph Höner zu Siederdissen, Kerstin Port, et al.. (2015). Improvement of liver function parameters in advanced HCV ‐associated liver cirrhosis by IFN ‐free antiviral therapies. Alimentary Pharmacology & Therapeutics. 42(7). 889–901. 87 indexed citations
8.
Deterding, Katja, Christoph Höner zu Siederdissen, Kerstin Port, et al.. (2015). Delayed early HCV RNA response during IFN-free therapy with sofosbuvir in interferon-ineligible patients with advanced cirrhosis. Zeitschrift für Gastroenterologie. 53(1). 1 indexed citations
9.
Deterding, Katja, Christoph Höner zu Siederdissen, Kerstin Port, et al.. (2015). Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies. Zeitschrift für Gastroenterologie. 53(8). 14 indexed citations
10.
Siederdissen, Christoph Höner zu, Benjamin Maasoumy, Katja Deterding, et al.. (2014). Eligibility and safety of the first interferon‐free therapy against hepatitis C in a real‐world setting. Liver International. 35(7). 1845–1852. 19 indexed citations
11.
Maasoumy, Benjamin, Kerstin Port, J Kirschner, et al.. (2013). Triple therapy for hepatitis C virus (HCV) infection: Eligibility, safety and efficacy in a real world setting. Zeitschrift für Gastroenterologie. 51(1).
12.
Maasoumy, Benjamin, Kerstin Port, Antoaneta A. Markova, et al.. (2013). 857 TRIPLE THERAPY FOR HEPATITIS C VIRUS (HCV) INFECTION IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS: LESSONS LEARNED FROM THE FIRST REAL-WORLD EXPERIENCE. Journal of Hepatology. 58. S351–S351. 2 indexed citations
13.
Maasoumy, Benjamin, Kerstin Port, Antoaneta A. Markova, et al.. (2013). Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting. PLoS ONE. 8(2). e55285–e55285. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Hézode Breakdown of academic impact, for papers by Karl‐Georg Simon Breakdown of academic impact, for papers by Manuela Curescu Breakdown of academic impact, for papers by Alison Uriel Breakdown of academic impact, for papers by Giampaolo Mangia Breakdown of academic impact, for papers by Beatriz Calle Serrano Breakdown of academic impact, for papers by E.J. Lawitz Breakdown of academic impact, for papers by C John Breakdown of academic impact, for papers by S. Roberts Breakdown of academic impact, for papers by P. Mélin
Rankless by CCL
2026